9-Ethyladenine derivatives as adenosine receptor antagonists: 2- and 8-substitution results in distinct selectivities
- 7 May 2003
- journal article
- research article
- Published by Springer Nature in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 367 (6) , 629-634
- https://doi.org/10.1007/s00210-003-0749-9
Abstract
9-Ethyladenine was used as the basis for a series of non-xanthine adenosine receptor antagonists at human adenosine receptors. The adenine-based compounds were substituted in 2- or 8-position with a variety of side chains including some aryl or arylalkynyl groups previously tested as 2-substituents in adenosine and 5'-N-ethylcarboxamidoadenosine (NECA) for their effect on agonist affinity. The affinity of the novel compounds was tested in radioligand binding assays (A1, A2A and A3) and inhibition of NECA-stimulated adenylyl cyclase activity (A2B) in membranes prepared from CHO cells stably transfected with the respective human receptor subtype. High affinity antagonists were identified for A1 (9-ethyl-8-phenyl-9H-adenine, compound 2; 6-(1-butylamino)-9-ethyl-8-phenyl-9H-purine, compound 3), A2A (8-ethoxy-9-ethyladenine; compound 8) and A3 (9-ethyl-8-phenylethynyl-9H-adenine, compound 5) with selectivities versus other receptor subtypes in the range of 10 to 600. These results demonstrate that adenine is a useful template for further development of high-affinity antagonists with distinct receptor selectivity profiles.Keywords
This publication has 21 references indexed in Scilit:
- Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine Derivatives as Highly Potent and Selective Human A3Adenosine Receptor Antagonists: Influence of the Chain at the N8Pyrazole NitrogenJournal of Medicinal Chemistry, 2000
- Adenosine receptors and their ligandsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2000
- Adenosine receptors: new opportunities for future drugsPublished by Elsevier ,2000
- Comparative pharmacology of human adenosine receptor subtypes – characterization of stably transfected receptors in CHO cellsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1997
- N6-Cyclopentyl-3‘-substituted-xylofuranosyladenosines: A New Class of Non-Xanthine Adenosine A1 Receptor AntagonistsJournal of Medicinal Chemistry, 1997
- The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.1996
- Derivatives of the Triazoloquinazoline Adenosine Antagonist (CGS15943) Are Selective for the Human A3Receptor SubtypeJournal of Medicinal Chemistry, 1996
- N6,9-Disubstituted adenines: potent, selective antagonists at the A1 adenosine receptorJournal of Medicinal Chemistry, 1991
- 2′,3′-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptorsEuropean Journal of Pharmacology, 1988
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973